| pubmed-article:8622064 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8622064 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:8622064 | lifeskim:mentions | umls-concept:C0085669 | lld:lifeskim |
| pubmed-article:8622064 | lifeskim:mentions | umls-concept:C0146224 | lld:lifeskim |
| pubmed-article:8622064 | lifeskim:mentions | umls-concept:C0332157 | lld:lifeskim |
| pubmed-article:8622064 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:8622064 | lifeskim:mentions | umls-concept:C0444889 | lld:lifeskim |
| pubmed-article:8622064 | lifeskim:mentions | umls-concept:C0205373 | lld:lifeskim |
| pubmed-article:8622064 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:8622064 | pubmed:dateCreated | 1996-6-18 | lld:pubmed |
| pubmed-article:8622064 | pubmed:abstractText | To determine the maximum-tolerated systemic exposure (MTSE) and exposure-limiting toxicity of continuous infusion topotecan in children with recurrent acute leukemia. | lld:pubmed |
| pubmed-article:8622064 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8622064 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8622064 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8622064 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8622064 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8622064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8622064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8622064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8622064 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8622064 | pubmed:month | May | lld:pubmed |
| pubmed-article:8622064 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:8622064 | pubmed:author | pubmed-author:EvansW EWE | lld:pubmed |
| pubmed-article:8622064 | pubmed:author | pubmed-author:PrattC BCB | lld:pubmed |
| pubmed-article:8622064 | pubmed:author | pubmed-author:FurmanW LWL | lld:pubmed |
| pubmed-article:8622064 | pubmed:author | pubmed-author:StewartC FCF | lld:pubmed |
| pubmed-article:8622064 | pubmed:author | pubmed-author:RiveraG KGK | lld:pubmed |
| pubmed-article:8622064 | pubmed:author | pubmed-author:BakerS DSD | lld:pubmed |
| pubmed-article:8622064 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8622064 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:8622064 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8622064 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8622064 | pubmed:pagination | 1504-11 | lld:pubmed |
| pubmed-article:8622064 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:meshHeading | pubmed-meshheading:8622064-... | lld:pubmed |
| pubmed-article:8622064 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8622064 | pubmed:articleTitle | Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia. | lld:pubmed |
| pubmed-article:8622064 | pubmed:affiliation | Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, USA. | lld:pubmed |
| pubmed-article:8622064 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8622064 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8622064 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8622064 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:8622064 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8622064 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8622064 | lld:pubmed |
